Recurrent Aphthous Stomatitis (Investigational Adjunct)
Investigational adjunct for severe recurrent aphthous stomatitis; topical corticosteroids, chlorhexidine, and (for severe disease) colchicine or systemic immunomodulators remain evidence-based.
Patient Summary
- Is this FDA-cleared for this use?
- Not FDA-cleared for recurrent aphthous stomatitis (canker sores). FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, June 2004). Use for recurrent aphthous stomatitis is investigational and considered inappropriate.
- What evidence exists?
- Tier C (investigational). No clinical study of leech therapy for canker sores was identified in PubMed; it is mentioned as an indication in Russian dental literature and practitioner texts, but no patient data for this condition could be verified. Evidence-based therapy for recurrent aphthous stomatitis (canker sores): topical corticosteroid (triamcinolone in Orabase, fluocinonide), topical anesthetics (lidocaine 2%), antimicrobial mouthrinses (chlorhexidine), and systemic therapy (colchicine, dapsone, thalidomide) for severe major aphthous ulcers. Workup for underlying systemic disease (Behcet syndrome, IBD, celiac disease, HIV, hematinic deficiencies) in major or recurrent cases. Most minor canker sores heal in 7-14 days without intervention.
- Main risks
- Bleeding from bite sites for 6 to 24 hours after detachment
- Worsening of oral inflammation or ulceration
- Bacterial superinfection of oral ulcers
- Local skin infection or, rarely, Aeromonas infection if leech placed near mouth
- Allergic reaction to leech saliva (uncommon)
- Intraoral leech placement is dangerous and not recommended
- Trigger of Behcet disease flares if underlying condition present
- Delay of workup for underlying systemic disease
- Who should not consider this
- Patients with suspected Behcet syndrome, IBD, celiac disease, or HIV
- Patients with hematinic deficiencies (iron, folate, B12) not yet replaced
- Patients with active oral candidiasis or herpes simplex
- Patients on anticoagulants, with hemophilia, or with anemia
- Patients who have not tried topical corticosteroid or antimicrobial mouthrinse
- Pregnant patients
- What to ask your clinician
- Have I been worked up for Behcet syndrome (genital and ocular involvement)?
- Have I been tested for iron, folate, B12, and celiac disease?
- Have I tried topical triamcinolone in Orabase or fluocinonide?
- Am I a candidate for colchicine or systemic therapy for severe major aphthous?
- Could oral candidiasis or herpes simplex be mimicking aphthous ulcers?
- What evidence specifically supports leech therapy for canker sores?
- What is the cost and is it covered by insurance? (typically not covered)
- When to seek urgent care
- New genital ulcers, eye redness, or skin lesions (possible Behcet syndrome)
- Abdominal pain, diarrhea, or rectal bleeding (possible inflammatory bowel disease)
- Severe ulcers with high fever and difficulty swallowing
- Ulcers persisting more than 3 weeks (rule out malignancy)
- Spreading redness, warmth, pus, or red streaks (cellulitis)
- Fever above 38.0 C / 100.4 F or chills
- Hives, facial or tongue swelling, throat tightness, or breathing difficulty
What this does NOT mean
- This is NOT FDA-cleared for recurrent aphthous stomatitis or canker sores.
- Mentions in the Russian-language literature, without verified patient data for this condition, do NOT establish efficacy versus topical corticosteroid, antimicrobial mouthrinse, or colchicine.
- It does NOT replace workup for Behcet syndrome, IBD, celiac disease, or hematinic deficiencies.
- It does NOT substitute for evidence-based topical therapy.
- It does NOT mean intraoral leech application is safe or appropriate.
Safety cross-references
Clinical Profile
- Category
- Other
- ICD-10
- K12.0, K12.04
- Safety tier
- High
Evidence Summary
Recurrent aphthous stomatitis (RAS) is recurrent painful oral ulcers, classified as minor, major, or herpetiform. Evidence-based topical therapy includes triamcinolone or clobetasol in adhesive bases, chlorhexidine rinses, topical anesthetics, and topical sucralfate. Severe or major RAS may warrant colchicine, dapsone, thalidomide (with strict regulatory controls), or systemic corticosteroids. Workup excludes Behcet disease, celiac disease, nutritional deficiencies (B12, folate, iron, zinc), HIV, and inflammatory bowel disease in atypical or severe cases. No controlled trial or case series of leech therapy for RAS was identified in PubMed, Europe PMC or ClinicalTrials.gov. The only mention found is in the Russian hirudology literature: Baskova and Isakhanyan (2004) list chronic recurrent aphthous stomatitis among dental indications, citing a conference review by Gileva (1997) that argues a clinical rationale but, as summarized, gives no patient numbers or outcomes for RAS. Oral mucosal placement of leeches is anatomically inappropriate and uniquely dangerous (airway, swallowing, hemorrhage); any rationale must be extra-oral application without plausible mucosal-targeted mechanism.
What the books describe
Below is a summary of what books on hirudotherapy say about this condition. These are the authors’ observations, not a proven effect and not a promise of results. Hirudotherapy has contraindications; the decision is made by a physician.
- Baskova and Isakhanyan name chronic recurrent aphthous stomatitis only in lists: among the indications for hirudotherapy in dentistry and among the conditions for which, in their retelling of Gileva’s review (1997), a comprehensive clinical and functional rationale for the use of leeches is presented[B1].
- What exactly Gileva’s “rationale” showed for aphthous stomatitis is not stated in the book: it gives no number of patients, no results and no follow-up periods[B1].
- The only observation in which the book mentions the word “stomatitis” is that of Zidra, Pozharitskaya, Simakova and co-authors (2003): among 105 patients with inflammatory diseases of the oral cavity, “stomatitis” (whether aphthous is not specified) and a number of other diseases are named; the book explains the positive effect by improved microcirculation in the mucosa, reduced congestion, metabolic processes, and the bactericidal and analgesic action of the leech’s secretion, while the results for stomatitis separately are not clear from the text[B1].
- Michalsen et al. do not write about aphthous stomatitis or ulcers of the oral mucosa.
- In the chapter on indications and contraindications, Baskova and Isakhanyan name, among others, the following cases in which hirudotherapy is contraindicated: hemophilia, hemorrhagic diatheses, anemias, low blood pressure (hypotension), acute vascular insufficiency (shock, collapse, fainting), emaciation, concurrent prescription of anticoagulants (especially with long-term, daily use), concurrent use of alcohol, external use of large doses of mercury preparations together with leeches, individual intolerance, and an extremely negative attitude of the patient toward leeches[B1].
- Michalsen et al. (chapter 8, Flecken and Michalsen) name hemophilia and concurrent use of anticoagulants as an absolute contraindication; in the same chapter, anemia and bone-marrow suppression, HIV infection, a known peptic ulcer or erosive gastritis, severe unstable disease of the internal organs or marked suppression of the immune system, a severe tendency to allergy, and emaciation of any cause are also listed as contraindications[B3].
- Baskova and Isakhanyan consider hirudotherapy relatively contraindicated where leeches could lead to cosmetic defects, advise refraining from it when body temperature is high, and call its use in pregnancy an open question; Michalsen et al. write that treatment involving blood loss is generally contraindicated in pregnancy and that, in their experience, during the acute stage of an infectious disease it can cause weakness and impair wound healing[B1][B3].
Treatment specifics
How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: where the society's reference books describe a protocol, it is shown in the clinician view — switch the audience selector in the top bar to “Clinician”.)
Contraindications
- Hemophilia or another bleeding disorder
- Taking anticoagulants (blood thinners such as warfarin or heparin)
- Anemia or suppressed blood formation
- Low blood pressure, shock, collapse or fainting
- Severe wasting (cachexia)
- Intolerance of leeches or a history of severe allergic reactions
- Pregnancy
- Stomach or duodenal ulcer, erosive gastritis
- Acute infectious disease or high fever
- Severe unstable illness, markedly weakened immunity (for example during chemotherapy) or HIV infection
- Drinking alcohol at the time of treatment
- No consent from the patient
- Intra-oral placement (absolute — airway and hemorrhage risk)
- Lip placement
- Active major RAS or herpetiform RAS with confluent ulcers
- Behcet disease without rheumatology workup
- Underlying nutritional deficiency not corrected
- Immunocompromise (HIV, IBD on immunosuppression)
Related Conditions
Cutaneous Lichen Planus (Localized)
Investigational use for localized cutaneous lichen planus refractory to topical corticosteroid; very limited case-report evidence.
Chronic Glossitis (Investigational Adjunct)
Highly investigational adjunct for chronic glossitis; no study in glossitis found; treating nutritional, infectious or allergic causes remains primary.
Atopic Eczema (Localized Refractory)
Investigational use for localized refractory eczema; evidence is limited to a few small studies without placebo or standard-care controls.
Metabolic Syndrome (Investigational Adjunct)
Investigational adjunct to lifestyle modification in metabolic syndrome; no clinical study in metabolic syndrome identified; weight loss, dietary modification, and pharmacotherapy remain primary.
References
- [B1]
Баскова И.П., Исаханян Г.С. Гирудотерапия. Наука и практика [Hirudotherapy: Science and Practice]
Monograph in Russian, 506 pp., ISBN 5-89527-058-1. Chapter 15: sensation at the bite, length of the session; secretion kininases and pain.
- [B3]
Michalsen A., Roth M., Dobos G. Medicinal Leech Therapy
ISBN 978-3-13-143581-1 / 978-1-58890-563-5. Chapter 9, p. 107: perceptions of the bite — a local dragging pain lasting around one to five minutes.
The information on this page is based on the hirudotherapy books listed under References and reflects the experience their authors describe. Sensations and results differ from person to person. This information is not medical advice, a diagnosis or a prescription, and it does not replace an examination by a physician. Do not stop or change any prescribed treatment without your physician. Hirudotherapy has contraindications.